Non-Alcoholic Steatohepatitis Treatment Global Market Report 2025

Published Sep 09, 2025

Length 250 Pages

SKU # BRC20383639

Description

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-alcoholic steatohepatitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for non-alcoholic steatohepatitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-alcoholic steatohepatitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Vitamin E And Pioglitazone; Ocaliva; Elafibranor; Selonsertib And cenicriviroc; Obeticholic Acid; Other Drugs Types

2) By Test Type: Blood Tests; Liver Biopsy; Imaging Procedures

3) By End User: Hospital Pharmacies; Retail And Specialty Pharmacies; Other End Users

Subsegments:

1) By Vitamin E And Pioglitazone: Vitamin E Supplements; Pioglitazone-Based Formulations.

2) By Ocaliva: Ocaliva (Obeticholic Acid) For NASH

3) By Elafibranor: Elafibranor-Based Treatments

4) By Selonsertib And Cenicriviroc: Selonsertib Formulations; Cenicriviroc Formulations

5) By Obeticholic Acid: Other Formulations Of Obeticholic Acid

6) By Other Drug Types: Novel Agents In Clinical Trials; Combination Therapies

Companies Mentioned: AstraZeneca PLC; Galmed Pharmaceuticals Ltd.; Genfit S.A.; Zydus Cadila Healthcare Limited; Bristol-Myers Squibb Company; Gilead Sciences Inc.; Novo Nordisk A/S; Immuron Ltd.; Inventiva Pharma SA; NGM Biopharmaceuticals Inc.; Galectin Therapeutics Inc.; Madrigal Pharmaceuticals Corporation; Intercept Pharmaceuticals Inc.; Cirius Therapeutics Inc.; Viking Therapeutics Inc.; Eli Lilly and Company; Terns Pharmaceuticals Inc.; Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Johnson & Johnson Private Limited; Sanofi S.A.; F. Hoffmann-La Roche Ltd.; C.H. Boehringer Sohn AG & Co. KG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Non-Alcoholic Steatohepatitis Treatment Market Characteristics
3. Non-Alcoholic Steatohepatitis Treatment Market Trends And Strategies
4. Non-Alcoholic Steatohepatitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Non-Alcoholic Steatohepatitis Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Non-Alcoholic Steatohepatitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Non-Alcoholic Steatohepatitis Treatment Market Growth Rate Analysis; 5.4. Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Non-Alcoholic Steatohepatitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Non-Alcoholic Steatohepatitis Treatment Total Addressable Market (TAM)
6. Non-Alcoholic Steatohepatitis Treatment Market Segmentation: 6.1. Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Vitamin E And Pioglitazone; Ocaliva; Elafibranor; Selonsertib And cenicriviroc; Obeticholic Acid; Other Drugs Types; 6.2. Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Blood Tests; Liver Biopsy; Imaging Procedures; 6.3. Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Retail And Specialty Pharmacies; Other End Users; 6.4. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Vitamin E And Pioglitazone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Vitamin E Supplements; Pioglitazone-Based Formulations; 6.5. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Ocaliva, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Ocaliva (Obeticholic Acid) For NASH; 6.6. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Elafibranor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Elafibranor-Based Treatments; 6.7. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Selonsertib And Cenicriviroc, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Selonsertib Formulations; Cenicriviroc Formulations; 6.8. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Obeticholic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Other Formulations Of Obeticholic Acid; 6.9. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Novel Agents In Clinical Trials; Combination Therapies
7. Non-Alcoholic Steatohepatitis Treatment Market Regional And Country Analysis: 7.1. Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market: 8.1. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Non-Alcoholic Steatohepatitis Treatment Market: 9.1. China Non-Alcoholic Steatohepatitis Treatment Market Overview; 9.2. China Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Non-Alcoholic Steatohepatitis Treatment Market: 10.1. India Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Non-Alcoholic Steatohepatitis Treatment Market: 11.1. Japan Non-Alcoholic Steatohepatitis Treatment Market Overview; 11.2. Japan Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Non-Alcoholic Steatohepatitis Treatment Market: 12.1. Australia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Non-Alcoholic Steatohepatitis Treatment Market: 13.1. Indonesia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Non-Alcoholic Steatohepatitis Treatment Market: 14.1. South Korea Non-Alcoholic Steatohepatitis Treatment Market Overview; 14.2. South Korea Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Non-Alcoholic Steatohepatitis Treatment Market: 15.1. Western Europe Non-Alcoholic Steatohepatitis Treatment Market Overview; 15.2. Western Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Non-Alcoholic Steatohepatitis Treatment Market: 16.1. UK Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Non-Alcoholic Steatohepatitis Treatment Market: 17.1. Germany Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Non-Alcoholic Steatohepatitis Treatment Market: 18.1. France Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Non-Alcoholic Steatohepatitis Treatment Market: 19.1. Italy Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Non-Alcoholic Steatohepatitis Treatment Market: 20.1. Spain Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market: 21.1. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market Overview; 21.2. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Non-Alcoholic Steatohepatitis Treatment Market: 22.1. Russia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Non-Alcoholic Steatohepatitis Treatment Market: 23.1. North America Non-Alcoholic Steatohepatitis Treatment Market Overview; 23.2. North America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Non-Alcoholic Steatohepatitis Treatment Market: 24.1. USA Non-Alcoholic Steatohepatitis Treatment Market Overview; 24.2. USA Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Non-Alcoholic Steatohepatitis Treatment Market: 25.1. Canada Non-Alcoholic Steatohepatitis Treatment Market Overview; 25.2. Canada Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Non-Alcoholic Steatohepatitis Treatment Market: 26.1. South America Non-Alcoholic Steatohepatitis Treatment Market Overview; 26.2. South America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Non-Alcoholic Steatohepatitis Treatment Market: 27.1. Brazil Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Non-Alcoholic Steatohepatitis Treatment Market: 28.1. Middle East Non-Alcoholic Steatohepatitis Treatment Market Overview; 28.2. Middle East Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Non-Alcoholic Steatohepatitis Treatment Market: 29.1. Africa Non-Alcoholic Steatohepatitis Treatment Market Overview; 29.2. Africa Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Non-Alcoholic Steatohepatitis Treatment Market Competitive Landscape And Company Profiles: 30.1. Non-Alcoholic Steatohepatitis Treatment Market Competitive Landscape; 30.2. Non-Alcoholic Steatohepatitis Treatment Market Company Profiles; 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Galmed Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Genfit S.A. Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Zydus Cadila Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Non-Alcoholic Steatohepatitis Treatment Market Other Major And Innovative Companies: 31.1. Gilead Sciences Inc.; 31.2. Novo Nordisk A/S; 31.3. Immuron Ltd.; 31.4. Inventiva Pharma SA; 31.5. NGM Biopharmaceuticals Inc.; 31.6. Galectin Therapeutics Inc.; 31.7. Madrigal Pharmaceuticals Corporation; 31.8. Intercept Pharmaceuticals Inc.; 31.9. Cirius Therapeutics Inc.; 31.10. Viking Therapeutics Inc.; 31.11. Eli Lilly and Company; 31.12. Terns Pharmaceuticals Inc.; 31.13. Pfizer Inc.; 31.14. Merck & Co. Inc.; 31.15. AbbVie Inc.
32. Global Non-Alcoholic Steatohepatitis Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Treatment Market
34. Recent Developments In The Non-Alcoholic Steatohepatitis Treatment Market
35. Non-Alcoholic Steatohepatitis Treatment Market High Potential Countries, Segments and Strategies: 35.1 Non-Alcoholic Steatohepatitis Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Non-Alcoholic Steatohepatitis Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Non-Alcoholic Steatohepatitis Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now